We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

115 hedge funds and large institutions have $642M invested in SANGAMO THERAPEUTICS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

789% more call options, than puts

Call options by funds: $93.6M | Put options by funds: $10.5M

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

57% more capital invested

Capital invested by funds: $408M → $642M (+$234M)

35% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 31

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

4% more funds holding

Funds holding: 111115 (+4)

Holders
115
Holders Change
+4
Holders Change %
+3.6%
% of All Funds
3.34%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.15%
New
22
Increased
42
Reduced
31
Closed
18
Calls
$93.6M
Puts
$10.5M
Net Calls
+$83.1M
Net Calls Change
+$5.8M
Name Holding Trade Value Shares
Change
Change in
Stake
WSA
26
Wall Street Associates
California
$4.31M -$216K -18,740 -6%
AGA
27
Altrinsic Global Advisors
Connecticut
$3.89M +$461K +40,000 +17%
Deutsche Bank
28
Deutsche Bank
Germany
$3.11M -$651K -56,573 -20%
UBS AM
29
UBS AM
Illinois
$3.06M +$18.4K +1,600 +0.7%
EAM
30
Eventide Asset Management
Massachusetts
$3.02M +$2.5M +217,300 New
Lord, Abbett & Co
31
Lord, Abbett & Co
New Jersey
$2.83M +$2.35M +203,967 New
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$2.77M +$2.3M +199,465 New
GC
33
Guggenheim Capital
Illinois
$2.76M +$2.29M +198,534 New
SCM
34
Sigma Capital Management
Connecticut
$2.43M +$2.01M +175,000 New
Invesco
35
Invesco
Georgia
$2.33M -$6.08M -528,272 -76%
BIM
36
BlackRock Investment Management
Delaware
$2.32M -$23.6K -2,050 -1%
CAM
37
Cormorant Asset Management
Massachusetts
$2.31M +$1.91M +166,200 New
Charles Schwab
38
Charles Schwab
California
$2.25M +$267K +23,200 +17%
DCM
39
Driehaus Capital Management
Illinois
$2.2M -$176K -15,308 -9%
CNB
40
City National Bank
California
$2.09M +$721K +62,620 +71%
GTC
41
Ghost Tree Capital
New York
$2.08M +$1.73M +150,000 New
FSA
42
Franklin Street Advisors
North Carolina
$2.01M -$55.3K -4,800 -3%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.97M -$25.8K -2,240 -2%
Wells Fargo
44
Wells Fargo
California
$1.66M +$431K +37,441 +45%
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$1.54M -$1.61M -140,029 -56%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.53M +$36.8K +3,200 +3%
TA
47
Teachers Advisors
New York
$1.46M +$86.1K +7,480 +8%
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.44M +$56.5K +4,908 +5%
EI
49
EAM Investors
California
$1.39M +$1.15M +99,893 New
Barclays
50
Barclays
United Kingdom
$1.31M +$1.02M +88,552 +724%

SGMO Hedge Fund Activity: Q4 2013 in Review

115 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2013, worth a combined $642M — up 57% from $408M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGMO positions and 18 closed out — a net gain of 4 holders — while 42 added to existing stakes and 31 trimmed.

The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $12.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $10.1M sold.

  • 115 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2013, up from 111 in Q3 2013.
  • Funds reported $642M of SANGAMO THERAPEUTICS INC stock for Q4 2013, up 57% quarter-over-quarter.
  • 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2013 and 18 closed out, a net change of +4 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2013 was SAC Capital Advisors, an estimated $12.9M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2013 was Perceptive Advisors, an estimated $10.1M sold.

Based on aggregated 13F filings for Q4 2013.